View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
Burgess Excel and the PDSA are urging veterinary surgeons and nurses to get their clients to sign up to the free PDSA Rabbit Wellbeing Challenge by the closing date of Friday 22 November.
According to the organisers, the PDSA Rabbit Wellbeing Challenge is designed to help all rabbit owners understand and meet their pets' five welfare needs - the five things that all pet rabbits' need to be healthy and happy. Since the campaign was launched in June, more than 1,000 rabbit owners have signed up to take the challenge, and veterinary practices are now being urged to ensure their clients take advantage of this free resource by visiting www.rabbitneeds.org.uk to register.
The Challenge website allows owners to take a monthly quiz to find out how well they are currently meeting their rabbits' needs, with advice on how to further improve their health and wellbeing. At the end of the challenge, owners will be presented with a Rabbit Wellbeing Challenge certificate and receive monthly vouchers together with money-off coupons for the Excel Feeding Plan. They will also be entered into a prize draw to win a 16gb iPad.
The Challenge is being featured on stickers on every pack of Burgess Excel Rabbit Nuggets. One million packs will have been sold by the final date for sign ups on the 22 November.
Burgess Pet Care Veterinary Surgeon, Suzanne Moyes, said: "With help from the veterinary community we really can make a difference by raising awareness about important rabbit welfare issues and in turn change rabbit owner behaviour. Working together, we are can improve the health and wellbeing of the UK's third most popular pet by educating pet owners, especially in relation to diet and regular veterinary check-ups."
Sean Wensley, Senior Veterinary Surgeon at PDSA, added: "Sadly, the welfare needs of pet rabbits are often not met. Common problems include a poor diet, living alone in a small hutch with no exercise run, and a lack of preventive healthcare. The PDSA Rabbit Wellbeing Challenge is a great tool for owners to assess how well they are currently meeting their rabbit's five welfare needs and to get advice on making practical, positive improvements. Most owners want their pets to be healthy and happy, and we hope this Challenge will help tackle some of the preventable health and welfare problems commonly seen in pet rabbits."
For further information on The PDSA Rabbit Wellbeing Challenge visit www.rabbitneeds.org.uk or for further details on the Burgess Excel Feeding Plan visit www.excelfedingplan.co.uk
Across Europe, the company has over 30 technical experts who get over 2,500 technical calls each year about Cushing’s.
The company also publishes the Dechra Academy, which provides a range of free online courses for vets.
There's also Dechra’s endocrinology app which was developed using data from the Royal Veterinary College’s VetCompass database to help vets diagnose and manage the endocrine disorders Addison’s disease (hypoadrenocorticism) and Cushing’s syndrome.
For owners, Dechra publishes the 'Suspecting Cushing’s' website and has created the Cushing’s monitoring app to help simplify the management process, improve compliance with medication and increase engagement in the dog’s care.
Sarah Musgrave, companion animal brand manager at Dechra, said: “Dechra has extensive experience in endocrinology.
"Cushing’s can be a challenge to identify, diagnose and manage and our ‘They’ve got Cushing’s. You’ve got us’ initiative demonstrates the comprehensive support that we have available for both vets and dog owners to help ensure that dogs with Cushing’s live long and healthy lives.”
https://www.dechra.co.uk/cushings-connect
Sheppard Robson, the architects behind the University of Liverpool’s Small Animal Teaching Hospital, have been celebrating this week after their design received a prestigious Royal Institute of British Architects (RIBA) North West Award.The Small Animal Teaching Hospital, located at the University’s Leahurst campus in Neston, was completed in 2007 and is considered to be one of the most advanced and complete animal veterinary facilities in the UK. It incorporates clinical services, undergraduate teaching and clinical research under one roof.The Royal Institute of British Architects (RIBA) annually presents regional awards for buildings that make a substantial contribution to the local environment and have high architectural standards.Ian Butler, Managing Partner at Sheppard Robson North, said: "The Small Animal Teaching Hospital at Liverpool University is a fantastic building. It is very strong and bold yet it is also simple and unfussy. It combines truly cutting edge teaching and research facilities with a sustainable building that blends into its environment. It is fantastic for our design to be lauded by RIBA. The Sheppard Robson team is very proud."The Small Animal Teaching Hospital, along with ten other North West buildings recognised by the regional judges, will now be considered for the National RIBA Awards in June.
Alternative remedies which could be dangerous to pets are being targeted by the Government in a major drive to improve animal health and welfare. Some herbal and homeopathic products are claiming medicinal benefits without scientific proof, meaning they may not properly treat or prevent serious diseases, leaving pets at risk.
The Veterinary Medicines Directorate’s (VMD) Director of Operations, John FitzGerald, said: "Some of these products are claiming to be effective and safe when no scientific evidence has been presented to us to show they are.
"Animal owners have a right to know if a product does what it claims. The products claim to treat diseases which can cause serious welfare problems and in some circumstances kill animals if not properly treated. So in some cases owners are giving remedies to their pets which don’t treat the problem."
A number of unauthorised products are being targeted, including:
From now on, the VMD will be contacting manufacturers to ensure that they demonstrate the products are safe and provide the benefits which they claim to. If this is not the case the manufacturers will be required to re-brand the products to make it clear they are not medicinal.
Supporting the action, British Veterinary Association President Harvey Locke said: "As veterinary surgeons we rely on the use of safe, effective and quality medicines for the health and welfare of animals under our care – and there must always be sound scientific evidence to back up medicinal claims made by the manufacturer of any product.
"Some of these unauthorised products may at the least be ineffective and at worst could cause harm because serious life-threatening diseases may go undiagnosed. We would urge animal owners always to check with their veterinary surgeon before giving any remedy or supplement to their pet."
Kruuse has launched a new extra large size Bovivet Hoof Bandage for use in the treatment of digital dermatitis (DD) in cattle.
According to the company, an estimated 70 per cent of dairy herds suffer with digital dermatitis and, if not treated, it can persist for months, causing pain and lameness to infected cows. Indeed, a paper1 presented at the BCVA 2011 Congress by Prof. N.B. Cook, Clinical Associate Professor at the School of Veterinary Medicine in Madison, USA, said that "lameness can systematically undermine the management of the dairy herd. No other disease has such fundamental and extensive effects on production, reproduction and risk of early herd removal."
The most effective way to fight DD has been found to be the management and treatment of individual animals. Traditional treatments have involved thoroughly washing the infected hoof, applying an antibiotic/drying agent, such as salicylic acid powder, and then applying a dressing that must remain in place usually for three days. However, it can be hard to correctly dose the salicyclic acid powder and there can be complications in ensuring that the dressing is correctly applied at the right pressure and that it stays in place. It can also be a risk to the user's health when mixing the powder.
Kruuse says this can be made easier by using the Bovivet complete Hoof Bandage along with Kruuse Hoof Gel 38%. Firstly, by using a gel, dosing is easy and more accurate, making it more economical per treatment; and, secondly, for the user, it reduces potential health risks from inhalation of the powder when mixing.
Stuart Wilson from Kruuse UK said: "Since the launch in the UK early last year, the hoof bandage has been very well received by cattle vets, but we were told by them that a larger version was needed in some cases. So Kruuse has produced the new extra large size 'red Jimmy Choos for moos'!"
Kruuse has produced the following instructional video to demonstrate the products' ease of use and versatility, and says that the estimated cost per hoof, assuming ten treatments from a bottle of the gel, is £2.71.
Reference
Great Workplaces by BVA is an accreditation scheme designed to recognise and reward positive workplace culture in both clinical and non-clinical veterinary workplaces.
The first webinar: 'How to have more good days at work' will be hosted by BVA Junior Vice President, Rob Williams (pictured), and VDS Training’s Carolyne Crowe.
The speakers will discuss strategies to support physical and psychological wellbeing at work and explore how to create a safe and inclusive team environment that supports everyone's needs.
Rob said: “This webinar series is designed to help your team identify practical steps to improve your veterinary workplace and create a working environment that allows the whole team to thrive.
"We’ll be diving into the first session with lots of practical tips and strategies and I hope to see many of you there.”
https://www.bva.co.uk/great-workplaces
https://mybva.bva.co.uk/ems-event-calendar/building-great-workplaces-how-to-have-more-good-days-at-work.html
The two-day event, being held in collaboration with the Veterinary Voices Hiking Group, offers a great opportunity to enjoy the great outdoors, get together, and raise vital funds for this crucial charity.
The event is being led by passionate hiking enthusiasts and Vetlife trustees Robyn Lowe and Paul Horwood.
Each day's route will cover 12-19 miles of stunning Northumberland coastline, but participants can opt for shorter distances.
Robyn said: "The Northumberland hike is more than just a walk – it's about coming together as a community, supporting one another, and embracing the mental health benefits of being in nature.
"We hope to see as many people as possible join us, not only to enjoy the experience but to help us continue Vetlife's essential work."
While fundraising is not compulsory, participants are encouraged to try and raise £365 for the charity, symbolising the number of days Vetlife provides support for the community each year.
To register your interest, email fundraising@vetlife.org.uk.
Photo: www.depositphotos.com
Alfaxan®, Vetoquinol's injectable general anaesthetic, is one year old this month. To celebrate the occasion, and the product's use by 860 UK practices in over 80,000 procedures so far, Vetoquinol is offering a free Alfaxan party bag.
The party bag includes an Alfaxan anaesthesia monitoring chart and an Alfaxan vet brochure with dosage chart and timer. In addition, everyone who claims a party bag will be entered into a lucky dip. Ten winners will be chosen at random to receive an oesophageal stethoscope kit, containing one normal stethoscope, with a removable head, and three Portex oesophageal stethoscope probes (small, medium and large) for monitoring patient’s heart and respiratory rate.
To claim your party bag, call the dedicated Alfaxan technical support line on 0800 345 7560 or email: MyAlfaxanPartyBag@vetoquinol.co.uk.
Vetoquinol also reports a very positive response to Alfaxan from the profession during its first year. Simon Boulton, one of Vetoquinol’s Veterinary Advisors, has been conducting wet labs across the country for the company. He said: "Vets have used the wet lab service to get me along to anaesthetize patients for the day using Alfaxan. I have had a great deal of positive feedback and the product is becoming more and more widely used. Extremely smooth and reliable inductions, followed by good cardiovascular and respiratory stability were the most noticeable features of Alfaxan anaesthesia, liked by both the vets anaesthetizing the patients and the nurses who monitor them."
Pfizer Animal Health has launched a dedicated Equine Business Unit to provide a higher level of service and a comprehensive range of products to equine vets across the UK.
Created following the merger with Fort Dodge, the Pfizer Equine Business Unit is headed by Ben Lacey MA Vet MB MRCVS, who has previously held both technical and sales roles at Pfizer. Ben and his team have a brief to offer a breadth of product, support and flexibility not previously available to equine vets.
The product range offered by the Pfizer Equine Business Unit includes the Equest range of parasiticides; the Duvaxyn vaccines for Equine Herpes Virus, West Nile Virus and Rotavirus and products such as Equimidine and Torbugesic. Also offered are existing Pfizer brands such as the Equip vaccine range, the antibiotic Excenel Sterile Powder, the NSAID Rimadyl for Horses and Depo-MedroneV.
Five experienced account managers with a strong track record in the equine sector have been appointed by Pfizer to build relationships with equine vet practices on a regional basis. They are:
South East England Mark BakerWest Midlands, Cheshire, Wales Laurie MayEast Anglia, East Midlands Penny McCannSouth West, South Wales Anna CunninghamThe North, Scotland Alexandra Cox
Ben Lacey said: "Building our new team and combining the highly regarded products offered previously by both Fort Dodge and Pfizer has proved a stimulating process. We've also worked closely with many of our existing practice customers to look at how we can develop the service we provide to them.
"We're now able to offer a product range which I believe is unrivalled in the market and a highly committed team of equine professionals, who share a vision and passion for equine health. We're looking forward to building our business with both existing and new customers in the months ahead."
The taskforce was established following the EU referendum result on 24 June, with the central purpose of putting the profession in charge of its future by maximising the opportunities and minimising the risks of Brexit.
Almost half of veterinary surgeons registering in the UK qualified from veterinary schools elsewhere in the EU. While the Government issued a statement in mid-July clarifying that as yet there has been no change to the rights and status of EU nationals in the UK or UK nationals in the EU, it is not clear whether this situation will continue once the UK has left the EU.
The Brexit Presidential Taskforce will consider, and proactively engage with, the many possible changes that could shape the future of the UK veterinary profession due to Brexit.
The members of the Taskforce are: the President of the College, Chris Tufnell; the CEO, Nick Stace; the Treasurer, Amanda Boag; Operations Director, Corrie McCann; Junior Vice-President, Stephen May; Acting Registrar, Eleanor Ferguson; Chair of Education, Susan Dawson; Head of Education, Chris Warman; Council member Stuart Reid; Chair of VN Council, Liz Cox; and Director of Strategic Communications, Lizzie Lockett.
The terms of reference include: considering how EU regulations currently impact the regulation of veterinary professionals in the UK, and making recommendations as to which should be maintained; looking at the issue of mutual recognition of veterinary graduates in Europe; considering workforce requirements and the implications of a new system of immigration; understanding the implications for the current RCVS agenda; considering whether a proactive RCVS agenda can influence any new UK legislation; reconsidering the College’s existing international strategy; and studying the financial impact on the College.
It was also agreed that the College should maintain communications with the British Veterinary Association and coordinate approaches where appropriate.
Dr Chris Tufnell, President of the RCVS, said: "Brexit has profound implications for our professions. The Presidential Taskforce is exploring all implications and will develop proposals that will seek to mitigate the risks and maximise the benefits that can flow to the veterinary professions and to animal welfare.
"We are working closely with representative bodies and others so that the veterinary professions have a coordinated and well executed plan in place. We are in discussions with all relevant Government departments, working collaboratively and constructively, ensuring that our voice is heard and our influence is felt."
The next meeting will be held on 15 September, with the third one scheduled for 9 November.
The College response welcomes Defra’s incorporation of many of the College’s longstanding recommendations for legislative change in its proposed reform of the VSA.
This includes giving the RCVS statutory powers to regulate veterinary businesses and protection of title for veterinary nurses, alongside reforms that could allow VNs to take on more roles and responsibilities.
It also supports enabling statutory regulation of the wider veterinary team, including allied professionals such as equine dental technicians and behaviourists, and a modernised registration and licensing system.
The response also backs an updated, forward-looking, fitness to practise regime with a greater range of sanctions available and interim powers of suspension.
In terms of the future governance structure for the RCVS, its response strongly favours Option 1 in Defra’s proposals - the ‘Royal College that regulates’ model – rather than Option 2, which would see the RCVS shorn of its broader public interest and professional leadership objectives and left with a purely regulatory remit.
RCVS President Professor Tim Parkin said: “It is our strong belief that the ‘Royal College that regulates’ model retains the best of both worlds, because it takes a proactive and holistic approach to regulation and fitness to practise.
“For example, professional leadership projects such as the Mind Matters Initiative and our reasonable adjustments campaign have opened up conversations around mental and physical health, and how we can better support our registrants to continue to meet professional standards in the public interest, while the RCVS Academy helps our registrants understand and navigate their professional responsibilities via innovative learning content.
“Furthermore, given the importance of supportive, preventative approaches to modern professional regulation, there can be no clear or fixed dividing line between the College’s regulatory and Royal College functions.
"Not only would Option 2 not create clarity, it would also risk undermining and leaving in limbo, without funding, much of the good work we have done with projects in mental health, workforce, environment and sustainability, and through our Fellowship.
“If you want a balanced and holistic approach to regulation for the benefit of animal health and welfare, public health and wider society, then please make sure you support Option 1 when you complete the consultation.”
https://www.rcvs.org.uk/veterinary-professionals/consultations/vsa-reform-time-for-change
The Federation of European Equine Veterinary Associations (FEEVA) and the European Federation of Farriers Associations (EFFA) have announced that they have joined forces to promote best practice in farriery.
The initiative is the result of recognition by both organisations that equine welfare is best served with the use of only properly trained farriers, working closely with veterinary surgeons as and when needed.
The organisations say that the main aims of the new partnership include:
The President of FEEVA, Professor Josh Slater said: "We look forward to working together at European level and encouraging member associations to do the same at national level, with the primary intention of enhancing equine health through first class farriery."
The RCVS Council has approved the new Strategic Plan designed to bring the College closer to its vision of enhancing society through improved animal health and welfare, over the next three years.
The Strategic Plan is founded on feedback from the profession and the public about what the College does well and where it could do better, and an analysis of how other leading regulators operate. It includes 35 actions, clustered under five themes, all centred on the purpose of setting, upholding and advancing veterinary standards.
For example, the College aims to introduce a service charter - for the public and the profession - of rights, expectations and responsibilities for each of its functions.
Nick Stace, RCVS CEO said: "This drive for excellent service lies at the heart of our focus on improvement.
"The concept of veterinary surgeons and veterinary nurses, as well as the public, being our 'customers', was one that unsettled the profession when it was first mooted. But I believe that only by ensuring that we focus relentlessly on improving how we interact with our customers will we deliver a service for the profession, the public, and, ultimately, the UK's animals, which is worthy of the name first-rate regulator."
Amongst other things, the Plan also commits to:
The Strategic Plan can be downloaded from www.rcvs.org.uk/strategy.
Also at its November meeting, Council approved:
More information on all of these topics will be available in the November issue of RCVS News, online shortly at www.rcvs.org.uk/publications.
You can also hear direct from the CEO via his post-Council video update: www.youtube.com/rcvsvideos.
Dechra Veterinary Products, manufacturer of the leading feline hyperthyroidism treatment Felimazole®, has launched a new website for cat owners about the disorder: www.hyperthyroidcat.co.uk
The website is an online version of Dechra's popular client booklets on feline hyperthyroidism and, since its launch, has averaged 500 unique visitors a month. With pages on diagnosis, treatment and even tips on how to give a pill to a cat, owners now have a place to go for more information and advice on the disease.
Matthew Olsen, product manager at Dechra Veterinary Products says: "This website is perfect for helping owners better understand and manage hyperthyroidism in their cat. It's also useful for practices as they now have somewhere to refer owners to for more information about the diagnosis and management of this complex hormonal disease."
Cards with the new website address are available for practices to hand to clients, along with waiting room posters that will serve as a further reminder of the new site. "The website allows clients to browse the site in the comfort of their own home and is also ideal for practices with limited storage space for client information materials," Dr Olsen continues. "The posters, cards and website enhance Dechra Veterinary Products' existing range of marketing materials available to vets and owners on the subject of feline hyperthyroidism."
Dechra also encourages practices that have their own websites to link directly to http://www.hyperthyroidcat.co.uk/. Practices can order posters and hand-out cards by contacting Dechra on 01743 441632 or email: info@dechra-uk.com
Researchers at the Royal Veterinary College (RVC) have developed a system that eliminates the need for antibiotics and resistance genes in the engineering of industrial and medical products.
The method involves safer, less costly alternatives and is well suited for industrial production of many biofuels and biopharmaceuticals. This research has been published in the online access journal BMC Biotechnology.
Genetic engineering underpins much of biotechnology, and antibiotic selection of engineered strains is a key tool. Unfortunately, antibiotic selection methods risk spreading resistance traits, particularly as biotechnology products move into the environment and clinic. There have been alternatives, but none are satisfactory for wide application.
Gene targeting is the insertion of DNA into specific sites or genes within the genome of selected cells in order to alter gene expression for a particular purpose.
While working on gene targeting in bacteria, RVC researchers discovered that a well-known interaction between a cell membrane synthesis gene and the biocide triclosan could be exploited for strain selection. Surprisingly, triclosan selection performs better than conventional antibiotic selection.
"We think this simple technology is well suited for industrial scale fermentations that produce a range of valuable products, including bio-fuels and bio-pharmaceuticals," said Dr Liam Good, at the Royal Veterinary College and lead researcher on the project. "More importantly, the new system is relatively safe and inexpensive, because the gene is native in all bacteria and triclosan is approved for use in many household applications."
The research was carried out with Dr Shan Goh of the Department of Cell and Molecular Biology, Karolinska Institute, Stockholm.
Insulation manufacturer Saint-Gobain Isover has published the results of a survey of 2000 homeowners which found that 36% are annoyed by noise made by neighbours' pets.
The Noise Report was commissioned to discover how many homeowners suffered with noisy next-door neighbours, to which the answer proved to be one in four.
According to the survey, which was carried out by Onepoll, Newcastle has the greatest percentage of owners who are disturbed by noise several times per day: 29.76% (click to enlarge infographic right).
In addition to noisy neighbours, 27% of homeowners said they are also disturbed by passing street traffic, while almost a third suffer from the sound of car and burglar alarms, and 36% are annoyed by noise from neighbours' pets.
The findings also suggested that external noise was more than just an irritation for homeowners. Almost a third of respondents said they lose sleep at night due to noise, while 15% claimed it causes them stress and anxiety. More than a fifth reported that they are unable to relax in their own home.
However, despite the impact of external noise on their quality of life, 45% of homeowners say they have not done anything about it. Only 6% report addressing the issue by installing insulation solutions in their homes.
Helen Tunnicliffe, head of marketing at Isover, said: "It is clear that noise from neighbours, traffic and other sources is a big problem for many homeowners. Not only is it irritating, it can have a major impact on people's emotional wellbeing.
"However, in spite of the seriousness of the issue, far too few people are taking measures to address it. There are many simple, easy-to-install solutions that prevent external noise in the home, such as insulation systems, which not only make the house warmer, but offer high acoustic performance too."
Alternatively, I suppose, move to Aberystwyth.
Biogal has announced the launch of the PCRun Molecular Detection Kit, designed to give PCR results in clinic or in the lab within an hour.
The new kit doesn't require any other equipment, such as a thermocycler.
PCRun is a molecular assay based on the isothermal amplification of part of the HapI gene. The company says it is intended for the qualitative detection of pathogenic species of Leptospires only.
The PCRun has been tested at the OEI Leptospira Reference Laboratory in Ireland, on sample materials including urine and kidney biopsies collected from cows experimentally infected with L. hardjo as well as kidney cells.
According to the company, no false positive results were observed in all 63 samples tested and there was excellent correlation between Real Time PCR and PCRun reactions.
Results of the study and a list of serovars tested with PCRun are available from Biogal. See: http://www.biogal.co.il/products/pcrun
There are a mix of online and in-person events.
On the 27th February at 7:00pm, Derek Flaherty, Professor in Veterinary Anaesthesia and Analgesia will cover common complications with veterinary anaesthesia and how you can deal with them during this in person event.
On the 29th April and 30th September, Tobi Wagner, Head of Cardiology at Southern Counties (pictured), will test your echo interpretation skills in an interactive online webinar.
On the 11th March, 1st July and 11th November, Tobi will be hosting Echo Clinics: small-group four-hour practical sessions which will look at how to obtain the necessary echocardiography views that can aid decision making in day-to-day clinical practice. Echo Clinics cost £375.
For nurses, Katie Foley and Tom Chapman will be hosting an in-person session looking at suture techniques on Thursday 6th February.
https://www.scvetspecialists.co.uk/vet-professionals/cpd
The awards highlight the special bond between pets and their owners, and brave stories from animals across the UK.
This year, Vets Now has partnered with StreetVet for the awards, donating £1 to the charity for each entry received.
The winner will receive a £500 voucher to spend on a pet friendly getaway at PetsPyjamas, a bespoke ‘Pet of the Year’ trophy and a personalised bundle of vet-recommended pet treats.
Owners can nominate their own pets, or members of the veterinary profession can nominate pets they know or have treated.
The awards will be open for nominations until 6th May 2024.
https://www.vets-now.com/pet-of-the-year
CEVA Animal Health is drawing vets' attention to research which has found a possible link between autism and pyrethrin-based flea shampoos.
Findings from the Childhood Autism Risks from Genetics and the Environment study, which is funded by the US National Institutes of Health, have raised the possibility that pyrethrins found in pet shampoos are linked to an increased risk of autism.
Mothers who used flea treatments containing pyrethrin based flea shampoos while pregnant were found to be twice as likely to have a child with an autistic spectrum disorder as those who did not.
The scientists who undertook the research have emphasised that the findings remain preliminary.
CEVA points out that while veterinary on-animal and household flea products have undergone extensive testing for safety and efficacy, parents may abandon flea control regimes over fears of pesticide use (as they abandoned the MMR vaccine).
Anxiety about the use of pesticides in the home is actually nothing new; a survey carried out in 2007, showed that two out of three pet owners were concerned about safety when using a pesticide-based flea spray in their homes.
CEVA highlights its own environmental flea control, Skoosh, as a possible alternative for concerned parents. Instead of pesticides, Skoosh uses inert silicones, commonly used in skin creams, make up, headlice lotions and oral medications, to physically engulf the fleas. CEVA says that Skoosh™ is not only effective against mature fleas, eggs and larvae but also physically prevents the hatching and development of pupae, which are not affected by traditional household sprays.
Ed's note: Fleas are something I know a little bit about (having worked on behalf of Novartis Animal Health for many years); I'd say that Program is another good alternative for pet owners that want to use a flea control product that does not put them into contact with pesticides. And no, I wasn't paid to write that, just force of habit!
Recent changes in the way veterinary schools teach clinical and practical skills, coupled with increasing financial pressure on students and new graduates, have triggered the Royal College of Veterinary Surgeons to review its guidelines for Extra-Mural Studies (EMS) and clinical education.
A requirement has been in place for the last 75 years that veterinary students ‘see practice' for at least 26 weeks in their clinical years.
The purpose of EMS has always been to ensure that veterinary students have the right mix of practical and theoretical teaching and understand the realities of commercial clinical practice before they graduate. This objective does not change, but the College's Education Policy and Specialisation Committee believes it is now time to look again at what is covered in the clinical curriculum of the undergraduate degree to ensure that guidelines are kept up to date.
EMS was last reviewed in 1996, but in the interim veterinary schools have introduced new ways of teaching practical and clinical aspects of the curriculum. There has also been an increase in the role played by the veterinary schools' own first opinion practices.
In addition, having to carry out EMS not only restricts students' capacity to work during the holidays, but often incurs substantial travel and accommodation expenses. With students facing increasing amounts of debt, the financial impact of EMS needs to be reviewed.
The review group, which will be chaired by RCVS Council Member and practitioner Dr Barry Johnson, will gather evidence from a broad range of stakeholders. It aims to make a report to Council by the end of 2009.
Forum Animal Health is launching a new programme designed for transition cows to help avoid milk fever relapses: the Milk Fever Pack.
According to the company, the new Milk Fever Pack provides a continuous and complete supply of readily available oral calcium to avoid relapses which also gives the cow extra support until her system is back in control. Unlike intravenous calcium, oral calcium will not suppress parathyroid hormone (PTH) release and therefore will not turn off the cow's natural mechanism to regulate blood calcium levels.
Each pack contains one sachet of Agger's® Fresh Cow which supplies essential calcium, energy and rehydrates the cow; and two tubes of Botonic® Calcium which create a mild metabolic acidosis to enable the cow to mobilise calcium efficiently.
Forum Animal Health says the new Milk Fever Pack has been developed in close collaboration with a leading veterinary nutritionist to allow veterinary surgeons to be involved at an earlier stage. The veterinary surgeon can then leave a follow-up protocol for the client to use, helping to avoid milk fever relapses. It gives veterinary surgeons a chance to introduce standard operating procedures into herd health plans bringing better control of milk fever on farms.
For more information, please contact Forum Animal Health on 01737 781416 or animal.health@forumgroup.co.uk.
The review coincided with a move last month from RUMA, the agricultural and food industry alliance which promotes responsible use of medicines in farm animals, to align with the EMA position.
The announcement means that under PVS guidelines, fluoroquinolones, 3rd and 4th generation cephalosporins and colistin will retain Class 3 status. This means they are only used when no other options are available and when supported by laboratory sensitivity testing – or exceptionally when all other options have failed.
Class 1 antibiotics form the standard prescribing list within responsible use guidelines and Class 2 are used only when sensitivity tests or clinical experience proves standard antibiotics are not effective. In all treatment decisions the health and welfare of the pigs must always take priority.
Betalactams with betalactamase inhibitors (clavulanic acid) were previously in the highest priority Class 3 but in light of the list defined by the EMA, which has been adopted by the Veterinary Medicines Directorate as well as RUMA, the PVS has reassessed the risk and moved them to Class 2 to align them with plain betalactams. This means they are still subject to voluntary restrictions, but their use would not necessarily be only as a last resort.
PVS president Mark White said that despite the ongoing review process and the potential to reclassify certain products, the Society’s underlying principles remain unchanged: "The total amount of all antibiotics used on pig farms to treat and prevent disease should be minimised, and the types of antibiotics used in pigs should be considered in light of the implications for antibiotic resistance challenges in both pigs and man.
"This policy is proving successful with AHDB Pork’s electronic pig medicine book (e-MB) recently showing that use of colistin appears to have fallen by over 70% in 2016 following its move to a Class 3 antibiotic in late 2015.
"We must also continue to be alert to the possibility of cross resistance, even in older antibiotics that have little or no use in humans. Risk must be acknowledged where it exists and overall reductions are still imperative."
RUMA has welcomed the review and alignment from the PVS. Secretary General John FitzGerald said: "Farmers and vets need boundaries within which to operate and clear objectives to meet, and we would urge all supply chains, from farmer to retailer, to align with the sector position on best practice use of antibiotics, as defined by each sector’s professional veterinary organisation."